A pair of businesses that Medtronic (NYSE: MD) planned to spin out into a new company could instead be sold to another medical device maker or other buyer for between $8 billion and $9 billion.
Reuters, citing sources familiar with with issue, reports that two med-tech companies have emerged as potential buyers of Medtronic's patient-monitoring and respiratory intervention businesses: Chicago-based GE Healthcare Technologies Inc. (NASDAQ: GEHC) and ICU Medical Inc. (NASDAQ: ICUI), a San Clemente,…
